Published in J Dent Res on August 01, 1988
Synthetic peptides analogous to the fimbrillin sequence inhibit adherence of Porphyromonas gingivalis. Infect Immun (1992) 1.90
Immunization with Porphyromonas (Bacteroides) gingivalis fimbriae protects against periodontal destruction. Infect Immun (1992) 1.82
Construction and characterization of a fimA mutant of Porphyromonas gingivalis. Infect Immun (1994) 1.73
Distribution of Porphyromonas gingivalis strains with fimA genotypes in periodontitis patients. J Clin Microbiol (1999) 1.58
Cloning, expression, and sequencing of a protease gene (tpr) from Porphyromonas gingivalis W83 in Escherichia coli. Infect Immun (1992) 1.44
Salivary receptors for recombinant fimbrillin of Porphyromonas gingivalis. Infect Immun (1994) 1.36
Characterization of an adherence and antigenic determinant of the ArgI protease of Porphyromonas gingivalis which is present on multiple gene products. Infect Immun (1996) 1.36
Isolation and characterization of a minor fimbria from Porphyromonas gingivalis. Infect Immun (1996) 1.29
Cysteine protease of Porphyromonas gingivalis 381 enhances binding of fimbriae to cultured human fibroblasts and matrix proteins. Infect Immun (1996) 1.25
Coinvasion of dentinal tubules by Porphyromonas gingivalis and Streptococcus gordonii depends upon binding specificity of streptococcal antigen I/II adhesin. Infect Immun (2000) 1.20
Binding of Porphyromonas gingivalis fimbriae to proline-rich glycoproteins in parotid saliva via a domain shared by major salivary components. Infect Immun (1998) 1.08
Expression of a functional Porphyromonas gingivalis fimbrillin polypeptide in Escherichia coli: purification, physicochemical and immunochemical characterization, and binding characteristics. Infect Immun (1993) 1.07
Biochemical characterization of Porphyromonas (Bacteroides) gingivalis collagenase. Infect Immun (1992) 1.06
Porphyromonas gingivalis fimbriae use beta2 integrin (CD11/CD18) on mouse peritoneal macrophages as a cellular receptor, and the CD18 beta chain plays a functional role in fimbrial signaling. Infect Immun (1998) 1.05
Molecular interactions of Porphyromonas gingivalis fimbriae with host proteins: kinetic analyses based on surface plasmon resonance. Infect Immun (1999) 0.99
Porphyromonas gingivalis fimbrillin is one of the fibronectin-binding proteins. Infect Immun (1996) 0.98
Active sites of salivary proline-rich protein for binding to Porphyromonas gingivalis fimbriae. Infect Immun (1997) 0.97
Expression of functional Porphyromonas gingivalis fimbrillin polypeptide domains on the surface of Streptococcus gordonii. Appl Environ Microbiol (1996) 0.93
Characterization of recombinant and native forms of a cell surface antigen of Porphyromonas (Bacteroides) gingivalis. Infect Immun (1993) 0.91
Depolarization of polymorphonuclear leukocytes by Porphyromonas (Bacteroides) gingivalis 381 in the absence of respiratory burst activation. Infect Immun (1991) 0.90
Inhibition of Porphyromonas gingivalis adhesion to Streptococcus gordonii by human submandibular-sublingual saliva. Infect Immun (1992) 0.87
Strain-specific colonization patterns and serum modulation of multi-species oral biofilm development. Anaerobe (2012) 0.84
Porphyromonas gingivalis fimbria-stimulated bone resorption is inhibited through binding of the fimbriae to fibronectin. Infect Immun (1997) 0.83
Transglutaminase 2 is essential for adherence of Porphyromonas gingivalis to host cells. Proc Natl Acad Sci U S A (2014) 0.77
Purification and characterization of a novel secondary fimbrial protein from Porphyromonas gulae. J Oral Microbiol (2012) 0.76
Porphyromonas gingivalis Fimbria-Induced Expression of Inflammatory Cytokines and Cyclooxygenase-2 in Mouse Macrophages and Its Inhibition by the Bioactive Compounds Fibronectin and Melatonin. ISRN Dent (2012) 0.76
Bacterial adherence in oral microbial ecology. Annu Rev Microbiol (1975) 11.44
Inhibition of bacterial adherence by secretory immunoglobulin A: a mechanism of antigen disposal. Science (1972) 6.80
Synthesis of insoluble dextran and its significance in the formation of gelatinous deposits by plaque-forming streptococci. Arch Oral Biol (1968) 6.55
Dextran-induced agglutination of Streptococcus mutans, and its potential role in the formation of microbial dental plaques. J Bacteriol (1969) 6.44
M protein-associated adherence of Streptococcus pyogenes to epithelial surfaces: prerequisite for virulence. Infect Immun (1972) 6.29
Comparative estimates of bacterial affinities and adsorption sites on hydroxyapatite surfaces. Infect Immun (1978) 5.73
A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med (1998) 5.67
Attachment of Bacteroides melaninogenicus subsp. asaccharolyticus to oral surfaces and its possible role in colonization of the mouth and of periodontal pockets. Infect Immun (1978) 5.20
Interbacterial aggregation of plaque bacteria. Arch Oral Biol (1970) 4.98
Dental caries. Annu Rev Med (1975) 4.89
Studies of the cultivable flora of normal human feces. Antonie Van Leeuwenhoek (1966) 4.47
Dental caries and alveolar bone loss in gnotobiotic rats infected with capsule forming streptococci of human origin. Arch Oral Biol (1966) 4.29
Adherence as an ecological determinant for streptococci in the human mouth. Arch Oral Biol (1971) 4.18
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1999) 4.15
Synthesis of extracellular dextran by cariogenic bacteria and its presence in human dental plaque. Arch Oral Biol (1967) 3.99
On the formation of dental plaques. J Periodontol (1973) 3.77
Parameters affecting the adherence and tissue tropisms of Streptococcus pyogenes. Infect Immun (1974) 3.73
Proportional distribution and relative adherence of Streptococcus miteor (mitis) on various surfaces in the human oral cavity. Infect Immun (1972) 3.70
Sorption of bacteria to human enamel powder. Arch Oral Biol (1970) 3.63
Adherence as a determinant of the presence of Streptococcus salivarius and Streptococcus sanguis on the human tooth surface. Arch Oral Biol (1970) 3.60
Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation (1997) 3.52
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA (1997) 3.51
Exercise tomographic thallium-201 imaging in patients with severe coronary artery disease and normal electrocardiograms. Ann Intern Med (1994) 3.38
Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet (1993) 3.34
Characteristics of some high molecular weight constituents with bacterial aggregating activity from whole saliva and dental plaque. Caries Res (1971) 3.24
ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol (1997) 3.14
Model delineating the effects of a salivary pellicle on the adsorption of Streptococcus miteor onto hydroxyapatite. Infect Immun (1976) 3.12
Influence of salivary components and extracellular polysaccharide synthesis from sucrose on the attachment of Streptococcus mutans 6715 to hydroxyapatite surfaces. Infect Immun (1977) 2.88
Inhibition of streptococcal attachment to receptors on human buccal epithelial cells by antigenically similar salivary glycoproteins. Infect Immun (1975) 2.76
Parameters that effect the adherence of Streptococcus salivarius to oral epithelial surfaces. J Dent Res (1972) 2.61
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol (1999) 2.58
Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J (2002) 2.49
Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation (1995) 2.33
Presence of an invertase-like enzyme and a sucrose permeation system in strains of Streptococcus mutans. Caries Res (1972) 2.29
ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol (1998) 2.27
Ability of Veillonella and Neisseria species to attach to oral surfaces and their proportions present indigenously. Infect Immun (1971) 2.24
Localization of a putative transcriptional regulator (ATRX) at pericentromeric heterochromatin and the short arms of acrocentric chromosomes. Proc Natl Acad Sci U S A (1999) 2.24
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol (1999) 2.23
Formation and significance of bacterial polysaccharides in caries etiology. Caries Res (1968) 2.19
Selective binding of blood group-reactive salivary mucins by Streptococcus mutans and other oral organisms. Infect Immun (1978) 2.17
Suppression of Candida albicans by human oral streptococci in gnotobiotic mice. Infect Immun (1973) 2.09
Severe exercise-induced ischemia does not identify high risk patients with normal left ventricular function and one- or two-vessel coronary artery disease. J Am Coll Cardiol (1994) 2.08
Bacteriocins from human and rodent streptococci. Arch Oral Biol (1969) 2.05
Estimates of the overall rate of growth of the intestinal microflora of hamsters, guinea pigs, and mice. J Bacteriol (1967) 2.04
ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome. Hum Mol Genet (1996) 1.91
Association of fimbriae with the hydrophobicity of Streptococcus sanguis FC-1 and adherence to salivary pellicles. Infect Immun (1983) 1.89
Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain. Nat Genet (1997) 1.88
Selective adherence as a determinant of the host tropisms of certain indigenous and pathogenic bacteria. Infect Immun (1976) 1.87
Adherent interactions which may affect microbial ecology in the mouth. J Dent Res (1984) 1.87
Comparative hydrophobicities of oral bacteria and their adherence to salivary pellicles. Infect Immun (1983) 1.86
Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation (1998) 1.86
ACC/AHA guidelines for exercise testing: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). Circulation (1997) 1.83
Influence of culture medium on the glucosyl transferase- and dextran-binding capacity of Streptococcus mutans 6715 cells. Infect Immun (1974) 1.80
Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study. Heart (2009) 1.69
Enzymatic modification of bacterial receptors on saliva-treated hydroxyapatite surfaces. Infect Immun (1982) 1.68
Concentration-dependent multiple binding sites on saliva-treated hydroxyapatite for Streptococcus sanguis. Infect Immun (1983) 1.67
Biochemical and immunological heterogeneity of Bacteroides melaninogenicus. Arch Oral Biol (1967) 1.62
Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction. J Am Coll Cardiol (2001) 1.58
Guidelines for the management of patients with chronic stable angina: treatment. Ann Intern Med (2001) 1.57
Amino acid fermentation by Fusobacterium nucleatum. Arch Oral Biol (1968) 1.56
Cost comparison of immediate angioplasty versus thrombolysis followed by conservative therapy for acute myocardial infarction: a randomized prospective trial. Mayo Coronary Care Unit and Catheterization Laboratory Groups. Mayo Clin Proc (1994) 1.52
Interdental localization of Streptococcus mutans as related to dental caries experience. Infect Immun (1974) 1.50
Induction of dental caries in gnotobiotic rats with a levan-forming streptococcus and a streptococcus isolated from subacute bacterial endocarditis. Arch Oral Biol (1968) 1.48
Outcome of noncardiac operations in patients with severe coronary artery disease successfully treated preoperatively with coronary angioplasty. Mayo Clin Proc (1992) 1.47
Do patients with left circumflex coronary artery-related acute myocardial infarction without ST-segment elevation benefit from reperfusion therapy? Am J Cardiol (1995) 1.47
Strains of Streptococcus mutans and Streptococcus sobrinus attach to different pellicle receptors. Infect Immun (1986) 1.46
Hydrolysis of levan by human plaque streptococci. Arch Oral Biol (1968) 1.46
Detection of myocardial infarction by dual-source coronary computed tomography angiography using quantitated myocardial scintigraphy as the reference standard. Heart (2009) 1.45
Ecology of human oral lactobacilli. Infect Immun (1972) 1.44
Guidelines for the management of patients with chronic stable angina: diagnosis and risk stratification. Ann Intern Med (2001) 1.44
Prognostic value of exercise thallium-201 imaging performed within 2 years of coronary artery bypass graft surgery. J Am Coll Cardiol (1998) 1.44
An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study). Am J Cardiol (2001) 1.43
Prediction of severe coronary artery disease and long-term outcome in patients undergoing vasodilator SPECT. J Nucl Cardiol (2001) 1.42
Studies of the predominant cultivable micro-organisms from the human tongue. Arch Oral Biol (1966) 1.42
Electrocardiographic prediction of myocardial area at risk. Mayo Clin Proc (1991) 1.41
Severity and response of chest pain during thrombolytic therapy for acute myocardial infarction: a useful indicator of myocardial salvage and infarct size. J Am Coll Cardiol (1993) 1.41
Accuracy of diagnosis of coronary artery disease by radionuclide management of left ventricular function during rest and exercise. Circulation (1981) 1.41
Is rest or exercise hypertension a cause of a false-positive exercise test? Chest (2000) 1.40
Myocardial revascularization before abdominal aortic aneurysmorrhaphy: effect of coronary angioplasty. Mayo Clin Proc (1993) 1.40
Inhibition of insoluble dextran synthesis, plaque formation and dental caries in hamsters by low molecular weight dextran. Arch Oral Biol (1969) 1.39